Whittier Trust Co. of Nevada Inc. grew its position in Avantor, Inc. (NYSE:AVTR – Free Report) by 5.3% in the 4th quarter, according to its most recent filing with the SEC. The firm owned 109,921 shares of the company’s stock after buying an additional 5,483 shares during the period. Whittier Trust Co. of Nevada Inc.’s holdings in Avantor were worth $2,315,000 at the end of the most recent reporting period.
Other hedge funds and other institutional investors also recently made changes to their positions in the company. MassMutual Private Wealth & Trust FSB increased its stake in shares of Avantor by 99.5% in the 4th quarter. MassMutual Private Wealth & Trust FSB now owns 1,253 shares of the company’s stock valued at $26,000 after buying an additional 625 shares during the period. Smartleaf Asset Management LLC increased its stake in shares of Avantor by 106.3% in the 4th quarter. Smartleaf Asset Management LLC now owns 1,611 shares of the company’s stock valued at $34,000 after buying an additional 830 shares during the period. Global Retirement Partners LLC increased its stake in shares of Avantor by 76.7% in the 4th quarter. Global Retirement Partners LLC now owns 2,459 shares of the company’s stock valued at $52,000 after buying an additional 1,067 shares during the period. UMB Bank n.a. increased its stake in shares of Avantor by 56.3% in the 4th quarter. UMB Bank n.a. now owns 2,981 shares of the company’s stock valued at $63,000 after buying an additional 1,074 shares during the period. Finally, AlphaQuest LLC acquired a new stake in shares of Avantor in the 4th quarter valued at $65,000. 95.08% of the stock is owned by institutional investors and hedge funds.
Avantor Stock Performance
AVTR stock opened at $16.61 on Friday. The firm has a market cap of $11.31 billion, a PE ratio of 15.97, a P/E/G ratio of 1.55 and a beta of 1.30. The business’s 50-day moving average price is $18.98 and its two-hundred day moving average price is $21.74. Avantor, Inc. has a 1-year low of $15.37 and a 1-year high of $28.00. The company has a current ratio of 1.07, a quick ratio of 0.70 and a debt-to-equity ratio of 0.54.
Wall Street Analyst Weigh In
AVTR has been the subject of several research reports. Cowen reissued a “buy” rating on shares of Avantor in a research note on Tuesday. Morgan Stanley reduced their price target on Avantor from $27.00 to $25.00 and set an “overweight” rating on the stock in a research report on Monday, February 10th. Stifel Nicolaus reduced their price target on Avantor from $28.00 to $26.00 and set a “buy” rating on the stock in a research report on Monday, February 10th. Citigroup reduced their price target on Avantor from $22.00 to $18.00 and set a “neutral” rating on the stock in a research report on Tuesday, March 4th. Finally, Royal Bank of Canada reduced their price target on Avantor from $33.00 to $31.00 and set an “outperform” rating on the stock in a research report on Monday, February 10th. Three investment analysts have rated the stock with a hold rating and ten have assigned a buy rating to the stock. According to MarketBeat, Avantor has a consensus rating of “Moderate Buy” and a consensus target price of $25.50.
Get Our Latest Research Report on Avantor
Insider Activity
In other news, EVP James Bramwell sold 3,758 shares of the business’s stock in a transaction dated Wednesday, February 26th. The stock was sold at an average price of $17.53, for a total value of $65,877.74. Following the sale, the executive vice president now directly owns 87,379 shares in the company, valued at $1,531,753.87. The trade was a 4.12 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is available at the SEC website. Also, CAO Steven W. Eck sold 4,907 shares of the business’s stock in a transaction dated Wednesday, February 26th. The shares were sold at an average price of $17.53, for a total value of $86,019.71. Following the completion of the sale, the chief accounting officer now owns 40,604 shares in the company, valued at approximately $711,788.12. This trade represents a 10.78 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Corporate insiders own 1.30% of the company’s stock.
About Avantor
Avantor, Inc engages in the provision of mission-critical products and services to customers in the biopharma, healthcare, education and government, advanced technologies, and applied materials industries in the Americas, Europe, Asia, the Middle East, and Africa. The company offers materials and consumables, such as purity chemicals and reagents, lab products and supplies, formulated silicone materials, customized excipients, customized single-use assemblies, process chromatography resins and columns, analytical sample prep kits, education and microbiology products, clinical trial kits, peristaltic pumps, and fluid handling tips.
Recommended Stories
- Five stocks we like better than Avantor
- Pros And Cons Of Monthly Dividend Stocks
- FedEx Delivers Another Crushing Blow to Its Stock Price
- 3 Ways To Invest In Coffee, Other Than Drinking It
- Analysts Stay Bullish on Rocket Lab as Signs of a Bottom Emerge
- Most Volatile Stocks, What Investors Need to Know
- Micron Stock Will Retest All-Time Highs This Year
Want to see what other hedge funds are holding AVTR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Avantor, Inc. (NYSE:AVTR – Free Report).
Receive News & Ratings for Avantor Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Avantor and related companies with MarketBeat.com's FREE daily email newsletter.